Manhattan Scientifics, Inc. (MHTX)

OTCMKTS: MHTX · Delayed Price · USD
0.0100
-0.0004 (-4.31%)
Jun 30, 2022 4:00 PM - Market closed

Company Description

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States.

It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

Manhattan Scientifics, Inc.
Manhattan Scientifics Logo
Country United States
Founded 1992
Industry Biotechnology
Sector Health Care
Employees 1

Contact Details

Address:
244 Fifth Avenue
New York, NY 10001
United States
Phone 212 541 2405

Stock Details

Ticker Symbol MHTX
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001099132
CUSIP Number 563122100
ISIN Number US5631221000
Employer ID 85-0460639
SIC Code 3699

Key Executives

Name Position
Marvin Maslow Founder and Chairman
Emmanuel Tsoupanarias President, Chief Executive Officer and Director
Leonard C. Friedman Secretary
Robert Romeo Proulx President of Imagion

Latest SEC Filings

Date Type Title
May 13, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
Apr 5, 2022 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2022 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Nov 15, 2021 10-Q Quarterly report [Sections 13 or 15(d)]
Aug 23, 2021 10-Q Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
May 17, 2021 10-Q Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2021 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Nov 16, 2020 10-Q Quarterly report [Sections 13 or 15(d)]